ATA501380A - Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen - Google Patents

Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen

Info

Publication number
ATA501380A
ATA501380A AT0501380A AT501380A ATA501380A AT A501380 A ATA501380 A AT A501380A AT 0501380 A AT0501380 A AT 0501380A AT 501380 A AT501380 A AT 501380A AT A501380 A ATA501380 A AT A501380A
Authority
AT
Austria
Prior art keywords
oxadiazoline
derivatives
salts
producing new
producing
Prior art date
Application number
AT0501380A
Other languages
English (en)
Other versions
AT375369B (de
Inventor
Kalman Chem Ing Takacs
Ilona Chem Ing Kiss
Antal Chem Ing Simay
Nagy Peter Chem Ing Literati
Maria Chem Ing Etyey
Marian Ecsery
Laszlo Dr Szekeres
Gyula Dr Papp
Sandor Dr Viragh
Eva Dr Udvardy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to AT328383A priority Critical patent/AT376219B/de
Publication of ATA501380A publication Critical patent/ATA501380A/de
Application granted granted Critical
Publication of AT375369B publication Critical patent/AT375369B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0501380A 1979-10-11 1980-10-09 Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen AT375369B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT328383A AT376219B (de) 1979-10-11 1983-09-15 Verfahren zur herstellung neuer 1,2,4-oxadiazolin -5-on-derivate sowie von deren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79CI1973A HU179951B (en) 1979-10-11 1979-10-11 Process for preparing 1,2,4-oxadiazolin-5-one derivatives and pharmaceutical compositions containing thereof

Publications (2)

Publication Number Publication Date
ATA501380A true ATA501380A (de) 1983-12-15
AT375369B AT375369B (de) 1984-07-25

Family

ID=10994764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0501380A AT375369B (de) 1979-10-11 1980-10-09 Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen

Country Status (23)

Country Link
US (1) US4365064A (de)
JP (1) JPS5661375A (de)
AT (1) AT375369B (de)
BE (1) BE885633A (de)
CA (1) CA1154019A (de)
CH (1) CH649547A5 (de)
CS (1) CS241032B2 (de)
DD (1) DD153550A5 (de)
DE (1) DE3037432A1 (de)
DK (1) DK149854C (de)
ES (1) ES8106725A1 (de)
FI (2) FI71932C (de)
FR (1) FR2467203A1 (de)
GB (1) GB2059967B (de)
HU (1) HU179951B (de)
IL (1) IL61175A (de)
IT (1) IT1129305B (de)
NL (1) NL8005586A (de)
NO (1) NO154795C (de)
PL (3) PL131451B1 (de)
SE (1) SE452158B (de)
SU (1) SU1087519A1 (de)
YU (1) YU41738B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives
WO2001070674A1 (en) * 2000-03-20 2001-09-27 N-Gene Research Laboratories Inc. Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
CA2894157A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
EP2935241A1 (de) * 2012-12-21 2015-10-28 Epizyme, Inc. Prmt5-inhibitor und verwendungen davon
EP2935240A1 (de) 2012-12-21 2015-10-28 Epizyme, Inc. Prmt5-inhibitor und verwendungen davon
PT2935222T (pt) 2012-12-21 2018-12-10 Epizyme Inc Inibidores de prmt5 e seus usos
US8940726B2 (en) 2012-12-21 2015-01-27 Epizyme, Inc. PRMT5 inhibitors and uses thereof
CA2953572A1 (en) 2014-08-04 2016-02-11 Epizyme, Inc. Prmt5 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (de) * 1967-12-07 1969-07-25
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives

Also Published As

Publication number Publication date
FI71318C (fi) 1986-12-19
GB2059967B (en) 1983-06-02
FI71932B (fi) 1986-11-28
FR2467203A1 (fr) 1981-04-17
IL61175A0 (en) 1980-11-30
CH649547A5 (de) 1985-05-31
IT8068555A0 (it) 1980-10-09
CS673780A2 (en) 1985-06-13
FI803219L (fi) 1981-04-12
AT375369B (de) 1984-07-25
DK149854B (da) 1986-10-13
YU41738B (en) 1987-12-31
BE885633A (fr) 1981-02-02
HU179951B (en) 1983-01-28
GB2059967A (en) 1981-04-29
DD153550A5 (de) 1982-01-13
NL8005586A (nl) 1981-04-14
DK149854C (da) 1987-04-21
SE8007025L (sv) 1981-04-12
FI803220L (fi) 1981-04-12
NO803044L (no) 1981-04-13
JPS5661375A (en) 1981-05-26
ES495819A0 (es) 1981-09-16
PL232293A1 (de) 1982-04-26
PL232292A1 (de) 1982-04-26
DE3037432A1 (de) 1981-05-27
SU1087519A1 (ru) 1984-04-23
YU259480A (en) 1984-02-29
IT1129305B (it) 1986-06-04
SE452158B (sv) 1987-11-16
IL61175A (en) 1984-08-31
FI71318B (fi) 1986-09-09
FR2467203B1 (de) 1985-03-22
NO154795B (no) 1986-09-15
DK429780A (da) 1981-04-12
PL227209A1 (de) 1981-12-11
PL131375B1 (en) 1984-11-30
PL131451B1 (en) 1984-11-30
CS241032B2 (en) 1986-03-13
CA1154019A (en) 1983-09-20
US4365064A (en) 1982-12-21
ES8106725A1 (es) 1981-09-16
FI71932C (fi) 1987-03-09
PL132131B1 (en) 1985-02-28
NO154795C (no) 1986-12-29

Similar Documents

Publication Publication Date Title
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT377254B (de) Verfahren zur herstellung neuer substituierter pyrrolidine und deren salzen
AT376971B (de) Verfahren zur herstellung neuer substituierter 2-mercaptoimidazole und von deren salzen
AT365175B (de) Verfahren zur herstellung von 5(6)-thiobenzimidazol-derivaten sowie von deren salzen
AT374173B (de) Verfahren zur herstellung neuer 2,6 -dialkoxybenzamide, ihrer salze und stereoisomeren
AT372946B (de) Verfahren zur herstellung neuer bis-aminopyridine und deren salze
ATA902383A (de) Verfahren zur herstellung neuer 2,3,4-trinor-1,5 -inter-m-phenylen-prostacyclin-i2-analoga und von deren salzen
AT375369B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen
AT381494B (de) Verfahren zur herstellung neuer 2,3,4-trinor-1,5inter-m-phenylen-prostacyclin-derivaten und von deren salzen
ATA265579A (de) Verfahren zur herstellung neuer substituierter aethanolamine und deren salzen
AT379393B (de) Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren
AT373582B (de) Verfahren zur herstellung neuer pyridoxinderivate und von deren salzen
AT373585B (de) Verfahren zur herstellung neuer, optisch aktiver oder racemischer 6,7-benzomorphan-derivate und deren saeureadditionssalze
AT373247B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazin -derivate sowie von deren salzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT361910B (de) Verfahren zur herstellung von neuen 2,4- dichlorphenyl-imidazolyl-aethanonen(olen) sowie von deren salzen
ATA63479A (de) Verfahren zur herstellung neuer 3,4-dihydro-2h-1,2-benzothiazin-1,1-dioxyde und deren salzen
ATA328383A (de) Verfahren zur herstellung neuer 1,2,4-qxadiazolin -5-on-derivaten sowie von deren salzen
AT374800B (de) Verfahren zur herstellung neuer guanidinothiazole und von deren salzen
AT351529B (de) Verfahren zur herstellung neuer 1,2,4-triazol- derivate und deren saeureadditionssalzen
AT375658B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazin- derivate sowie von deren salzen
AT382371B (de) Verfahren zur herstellung von neuen iminderivaten, sowie von deren salzen
AT374178B (de) Verfahren zur herstellung neuer indolderivate und deren salzen
ATA278280A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydroisoindolderivat und von deren salzen
ATA313783A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydroisoindolderivaten und von deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee